Physician profile
Calvin D Dalton
NPI 1831205509
$6,605.38
in general payments reported to CMS, 2019-2025
18 companies · $849 in 2025
The $849 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.94 · 2020: $229 · 2021: $406 · 2022: $2,127 · 2023: $1,768 · 2024: $1,154 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681 · Travel and Lodging: $1,072 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,680.86 |
| Travel and Lodging | $1,071.67 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,530.06 | 2021-2025 | Myday Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $1,229.93 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $957.00 | 2020-2025 | Cequa |
| Bausch & Lomb Americas INC. | $644.90 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $587.51 | 2022-2024 | Tyrvaya |
| Harrow Eye, LLC | $389.29 | 2024-2025 | Vevye |
| Alcon Vision LLC | $278.21 | 2022-2025 | Precision7, Precision 1, Rocklatan |
| Johnson & Johnson Vision Care, INC. | $255.07 | 2019-2024 | Acuvue, Axert |
| Allergan, INC. | $217.72 | 2020-2022 | |
| Dompe US, INC. | $116.25 | 2024-2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $95.08 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $91.80 | 2024-2025 | Xdemvy |
| Abbvie INC. | $55.37 | 2023-2024 | Vuity, Alphagan P, Lumigan |
| Johnson & Johnson Surgical Vision, INC. | $52.38 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.80 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $28.65 | 2022 | |
| Maculogix, INC. | $23.80 | 2021 | |
| Kala Pharmaceuticals, INC. | $21.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.